Literature DB >> 3333063

Tissue response to biodegradable injectable microcapsules.

G E Visscher1, M A Robison, G J Argentieri.   

Abstract

Biodegradable microcapsules have been shown to be capable of delivering a sustained release of various medicinal agents. We have observed an initial minimal, sharply localized, acute inflammatory response to intramuscularly injected microcapsules produced from various polymers. Evaluation of later time points has shown a diminishing macrophage, foreign body giant cell, and connective tissue response along with actual microcapsule degradation. No fibrous capsule formation was seen. Complete resolution of the tissue reaction can be expected, with the time frame depending upon the polymer utilized. Published experimental results report similar minor tissue responses to a variety of injected biodegradable microcapsules.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3333063     DOI: 10.1177/088532828700200103

Source DB:  PubMed          Journal:  J Biomater Appl        ISSN: 0885-3282            Impact factor:   2.646


  8 in total

1.  Treatment of tuberculosis using a combination of sustained-release rifampin-loaded microspheres and oral dosing with isoniazid.

Authors:  D C Quenelle; G A Winchester; J K Staas; E L Barrow; W W Barrow
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

2.  Efficacy of microencapsulated rifampin in Mycobacterium tuberculosis-infected mice.

Authors:  D C Quenelle; J K Staas; G A Winchester; E L Barrow; W W Barrow
Journal:  Antimicrob Agents Chemother       Date:  1999-05       Impact factor: 5.191

3.  Biodegradable microparticles as controlled release antigen delivery systems.

Authors:  D T O'Hagan; D Rahman; J P McGee; H Jeffery; M C Davies; P Williams; S S Davis; S J Challacombe
Journal:  Immunology       Date:  1991-06       Impact factor: 7.397

4.  Enhanced secretory IgA and systemic IgG antibody responses after oral immunization with biodegradable microparticles containing antigen.

Authors:  S J Challacombe; D Rahman; H Jeffery; S S Davis; D T O'Hagan
Journal:  Immunology       Date:  1992-05       Impact factor: 7.397

5.  Preparation of three-month depot injectable microspheres of leuprorelin acetate using biodegradable polymers.

Authors:  H Okada; Y Doken; Y Ogawa; H Toguchi
Journal:  Pharm Res       Date:  1994-08       Impact factor: 4.200

6.  Biodegradable and biocompatible poly(DL-lactide-co-glycolide) microspheres as an adjuvant for staphylococcal enterotoxin B toxoid which enhances the level of toxin-neutralizing antibodies.

Authors:  J H Eldridge; J K Staas; J A Meulbroek; T R Tice; R M Gilley
Journal:  Infect Immun       Date:  1991-09       Impact factor: 3.441

7.  Use of microsphere technology for targeted delivery of rifampin to Mycobacterium tuberculosis-infected macrophages.

Authors:  E L Barrow; G A Winchester; J K Staas; D C Quenelle; W W Barrow
Journal:  Antimicrob Agents Chemother       Date:  1998-10       Impact factor: 5.191

8.  Encapsulated Brucella ovis Lacking a Putative ATP-Binding Cassette Transporter (ΔabcBA) Protects against Wild Type Brucella ovis in Rams.

Authors:  Ana Patrícia C Silva; Auricélio A Macêdo; Luciana F Costa; Cláudia E Rocha; Luize N N Garcia; Jade R D Farias; Priscilla P R Gomes; Gustavo C Teixeira; Kessler W J Fonseca; Andréa R F Maia; Gabriela G Neves; Everton L Romão; Teane M A Silva; Juliana P S Mol; Renata M Oliveira; Márcio S S Araújo; Ernane F Nascimento; Olindo A Martins-Filho; Humberto M Brandão; Tatiane A Paixão; Renato L Santos
Journal:  PLoS One       Date:  2015-08-28       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.